Works matching IS 02704137 AND DT 2010 AND VI 70 AND IP 12

Results: 11

Methoxychalcone induces cell-cycle arrest and apoptosis in human hormone-resistant prostate cancer cells through PI 3-kinase-independent inhibition of mTOR pathways.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1295, doi. 10.1002/pros.21165

By:

Sun, Yu-Wei;
Huang, Wei-Jan;
Hsiao, Che-Jen;
Chen, Yi-Cheng;
Lu, Pin-Hsuan;
Guh, Jih-Hwa

Publication type:

Article

Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1340, doi. 10.1002/pros.21169

By:

Festuccia, Claudio;
Dondi, Donatella;
Piccolella, Margherita;
Locatelli, Alessia;
Gravina, Giovanni Luca;
Tombolini, Vincenzo;
Motta, Marcella

Publication type:

Article

Saporin toxin-conjugated monoclonal antibody targeting prostate-specific membrane antigen has potent anticancer activity.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1286, doi. 10.1002/pros.21164

By:

Kuroda, Kenji;
Liu, He;
Kim, Sae;
Guo, Ming;
Navarro, Vincent;
Bander, Neil H.

Publication type:

Article

Nuclear roundness variance predicts prostate cancer progression, metastasis, and death: A prospective evaluation with up to 25 years of follow-up after radical prostatectomy.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1333, doi. 10.1002/pros.21168

By:

Veltri, Robert W.;
Isharwal, Sumit;
Miller, M. Craig;
Epstein, Jonathan I.;
Partin, Alan W.

Publication type:

Article

Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1350, doi. 10.1002/pros.21170

By:

Mannowetz, Nadja;
Würdinger, Robert;
Zippel, Andrea;
Aumüller, Gerhard;
Wennemuth, Gunther

Publication type:

Article

Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1274, doi. 10.1002/pros.21163

By:

Mahajan, Kiran;
Challa, Sridevi;
Coppola, Domenico;
Lawrence, Harshani;
Luo, Yunting;
Gevariya, Harsukh;
Zhu, Weiwei;
Chen, Y. Ann;
Lawrence, Nicholas J.;
Mahajan, Nupam P.

Publication type:

Article

Predictive models before and after radical prostatectomy.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1371, doi. 10.1002/pros.21159

By:

Capitanio, Umberto;
Briganti, Alberto;
Gallina, Andrea;
Suardi, Nazareno;
Karakiewicz, Pierre I.;
Montorsi, Francesco;
Scattoni, Vincenzo

Publication type:

Article

Eight-plex iTRAQ analysis of variant metastatic human prostate cancer cells identifies candidate biomarkers of progression: An exploratory study.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1313, doi. 10.1002/pros.21167

By:

Glen, Adam;
Evans, Caroline A.;
Gan, Chee S.;
Cross, Simon S.;
Hamdy, Freddie C.;
Gibbins, Jonathan;
Lippitt, Jenny;
Eaton, Colby L.;
Noirel, Josselin;
Wright, Phillip C.;
Rehman, Ishtiaq

Publication type:

Article

Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1265, doi. 10.1002/pros.21162

By:

Zhang, Haitao;
Fang, Jian;
Yao, Dian;
Wu, Yue;
Ip, Clement;
Dong, Yan

Publication type:

Article

The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1359, doi. 10.1002/pros.21173

By:

Lin, Edwin;
Wang, Qingcai;
Swenson, Stephen;
Jadvar, Hossein;
Groshen, Susan;
Ye, Wei;
Markland, Francis S.;
Pinski, Jacek

Publication type:

Article

The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.

Published in:

Prostate, 2010, v. 70, n. 12, p. 1307, doi. 10.1002/pros.21166

By:

Geier, Rinat;
Adler, Shulamit;
Rashid, Gloria;
Klein, Ami

Publication type:

Article